Drug Report History #90434
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.
| Field | Version v9-EN | Version v3-EN |
|---|---|---|
| Language | English | English |
| Date Updated | 2019-08-01 (Updated) | 2019-07-31 |
| Drug Identification Number | 02279444 | 02279444 |
| Brand name | GAMMAGARD LIQUID | GAMMAGARD LIQUID |
| Common or Proper name | GAMMAGARD LIQUID, Immunoglobulin Intravenous | GAMMAGARD LIQUID, Immunoglobulin Intravenous |
| Company Name | SHIRE PHARMA CANADA ULC | SHIRE PHARMA CANADA ULC |
| Ingredients | IMMUNOGLOBULIN | IMMUNOGLOBULIN |
| Strength(s) | 10% | 10% |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging size | 2.5g/ 25mL, 5g/ 50mL, 10g/ 100mL, and 30g/ 300mL (Updated) | 1g/ 10mL, 2.5g/ 25mL, 5g/ 50mL, 10g/ 100mL, 20g/ 200mL, and |
| ATC code | J06BA | J06BA |
| ATC description | IMMUNOGLOBULINS | IMMUNOGLOBULINS |
| Reason for shortage | Shortage of an active ingredient. | Shortage of an active ingredient. |
| Anticipated start date | 2019-07-31 | 2019-07-31 |
| Actual start date | 2019-07-31 | 2019-07-31 |
| Estimated end date | 2019-09-30 | 2019-09-30 |
| Actual end date | ||
| Shortage status | Actual shortage (Updated) | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Temporary shortage in some product size formats. 2.5g/ 25mL, 5g/ 50mL, 10g/ 100mL, and 30g/ 300mL (Updated) | Temporary shortage in some product size formats. |
| Health Canada comments |